Related by context. All words. (Click for frequent words.) 66 immunohistochemical analysis 65 immunohistochemical 65 immunostaining 65 quantitative PCR 64 RRM1 64 qRT PCR 63 TMPRSS2 ERG 63 RQ PCR 63 Immunohistochemical staining 63 tumorigenicity 63 immunohistochemistry IHC 63 prostate carcinoma 63 HER2 expression 62 immunohistochemical staining 62 immunoblotting 62 CIN2 + 62 quantitative RT PCR 62 Western blotting 62 Immunohistochemistry 62 splice variants 62 miRview mets 62 endoglin 62 prognostic markers 62 RT qPCR 62 miRview squamous 61 Immunohistochemical 61 Annexin V 61 APTIMA HPV 61 K ras mutations 61 situ hybridization 60 Anticalins ® 60 PCR assay 60 carcinoembryonic antigen 60 PCA3 gene 60 MAGE A3 60 VerifyNow P#Y# 60 Genotypic 60 lactate dehydrogenase LDH 60 KRAS mutation 59 sensitivity specificity 59 Prognostic 59 micrometastasis 59 Histological 59 prognostic significance 59 microsatellite instability 59 BRAF V#E mutation 59 cTnI 59 mutational status 59 FDG-PET/CT 59 histopathologic examination 59 molecular biomarkers 59 electrophysiologic 59 MTT assay 59 Quantitative RT PCR 59 nodal metastasis 59 siRNA knockdown 59 immunoblot 59 transthoracic 59 Antigen CEA 59 intraobserver 59 Roche AmpliChip 59 D Dimer 59 immunocytochemistry 59 prognostic biomarker 59 vivo potency 59 immunofluorescent 59 ABL1 59 ERBB2 59 #F FDG PET 59 p# antigen 59 urine cytology 58 quantitative reverse transcriptase 58 SELDI TOF MS 58 histopathological 58 microarray analysis 58 bronchial lavage 58 chemosensitivity 58 Flow cytometry 58 biodistribution 58 pain palliation 58 microRNA profiling 58 FDG uptake 58 predictive biomarker 58 bronchoalveolar lavage 58 HERmark assay 58 mutational analysis 58 DNA methylation markers 58 F FDG PET 58 EpCAM 58 Trofex 58 DCE MRI 58 enzyme immunoassay EIA 58 AGTR1 58 Cervista HPV HR 58 promoter methylation 58 miRview ™ squamous 58 p# biomarker 58 histopathologic 58 Clusterin 58 semiquantitative 58 Situ Hybridization FISH 58 eTag assays 58 molecular diagnostic assay 58 plasma pharmacokinetics 58 Epidermal Growth Factor Receptor 58 troponins 58 pharmacodynamic markers 58 CD#c 58 Immunohistochemical analysis 58 S. maltophilia 58 transiently transfected 58 ELISPOT 58 EQ 5D 58 multiplexed assays 58 vitro experiments 58 genomic alterations 58 reaction RT PCR 58 comparative genomic hybridization 58 Her2/neu 58 Leydig cell 58 co receptor tropism 57 myocardial necrosis 57 NPM1 mutation 57 Cystatin C 57 transthoracic echocardiography 57 ImmuKnow 57 RECIST Response Evaluation Criteria 57 Mass Spectrometry MS 57 RT PCR 57 florbetaben 57 CA9 SCAN 57 BN# [004] 57 FLT3 57 Septin 9 57 gastric carcinoma 57 biopsy specimens 57 Subgroup analysis 57 methylation patterns 57 clinicopathological features 57 immunochemical 57 cardiac troponin T 57 thyroglobulin 57 multiplex PCR 57 bFGF 57 gastric carcinomas 57 situ hybridisation 57 anti JCV antibodies 57 ELISpot 57 progesterone receptor PR 57 MGMT gene 57 interobserver agreement 57 immunohistochemistry 57 cytogenic 57 Immunofluorescence 57 Quantitative PCR 57 reverse transcriptase polymerase chain 57 PITX2 57 WT1 57 myeloperoxidase 57 mass spectrometric 57 prognostic variables 57 genotypic resistance 57 cytotoxicity assays 57 Histologic 57 intact parathyroid hormone 57 urothelial carcinoma 57 Pharmacodynamic 57 somatic mutations 57 NSCLC tumors 57 biopsied tissue 57 prognostic indicators 57 heparanase 57 oligonucleotide microarray 57 multiparametric 57 morphologic 57 malignant nodules 57 sequence homology 57 Histopathologic 57 enzyme linked immunosorbent 57 colon carcinoma 57 peripheral blood mononuclear 57 pelvic ultrasound 57 CD# expression [002] 57 CD# expression [001] 57 metastatic lymph nodes 57 flow cytometric 56 HERmark 56 p tau 56 RT PCR assay 56 metabolite identification 56 ultrasonographic 56 virulence genes 56 antimicrobial susceptibility testing 56 Alkaline Phosphatase 56 miRNA expression 56 lung nodule 56 aCGH 56 surgically resected 56 VKORC1 56 multiplex assay 56 gene expression microarrays 56 tumor biopsies 56 Epigenomics proprietary 56 QRT PCR 56 transcriptomic 56 vitro assay 56 metabolite concentrations 56 debulking surgery 56 MammaPrint R 56 gene polymorphisms 56 chromatin immunoprecipitation ChIP 56 diagnostic modality 56 Ki# 56 prostate carcinomas 56 magnetic resonance spectroscopy MRS 56 biomarker assays 56 tumor hypoxia 56 T#I [002] 56 bronchial epithelial cells 56 KRAS mutations 56 isotope dilution 56 indirect immunofluorescence 56 hepatocellular carcinomas 56 TRAIL R1 56 LC MALDI 56 PET tracer 56 myocardial viability 56 TOP2A 56 Microarray analysis 56 hERG 56 mRNA expression 56 folate receptor 56 ABCB1 56 UGT#A# 56 methylation markers 56 viral kinetics 56 methylated DNA 56 metabolomic profiles 56 quantitative computed tomography 56 B7 H3 56 Mutation Detection 56 normal karyotype 56 non squamous histology 56 CTNNB1 56 galiximab 56 reaction PCR 56 Troponin T 56 T SPOT.TB 56 constitutively expressed 56 angiographically 56 gene amplification 56 AmpliChip 56 MALDI MS 56 PCa 56 gene expression profiling 56 vimentin 56 pT3 56 transfection efficiency 56 supernatants 56 radiotracers 56 HAAH 56 breast pancreatic 56 lymphomas leukemias 56 variant allele 56 bioluminescent imaging 56 Estrogen Receptor 56 sputum cytology 55 gastric adenocarcinoma 55 syngeneic 55 FCGR3A 55 index assay IVDMIA 55 chromatin immunoprecipitation 55 Histopathological 55 cell lysates 55 microarray gene expression 55 KRAS mutation status 55 #F FDG 55 Lp PLA 2 55 mRNA transcripts 55 tryptase 55 fosbretabulin 55 humanised monoclonal antibody 55 NGAL 55 hypermethylated 55 genetic biomarkers 55 pharmacodynamic parameters 55 PCA3 55 Cathepsin B 55 Transesophageal 55 annexin V 55 guaiac 55 MGd 55 putative biomarkers 55 culture supernatants 55 HLA DQ2 55 resected tumor 55 serum biomarkers 55 iTRAQ 55 independent prognostic marker 55 ImmuKnow R 55 hematological parameters 55 proteomic analyzes 55 EUS FNA 55 CEACAM1 55 urine dipstick 55 Cytochrome P# 55 ChemoFx ® 55 ERalpha 55 biomarker assay 55 completely resected 55 differentially expressed proteins 55 S#A# [002] 55 ChIP chip 55 quantitative gene expression 55 AtherOx 55 NMP# 55 genomic biomarker 55 SNP rs# [001] 55 quantitative polymerase chain 55 needle aspiration 55 Gamma Imaging BSGI 55 histological subtype 55 immunoreactivity 55 molecular diagnostic assays 55 perfusion imaging 55 acid phosphatase PAP 55 quantitative coronary angiography 55 gefitinib Iressa 55 Endometrial 55 histologic examination 55 radiotherapy RT 55 transrectal ultrasound guided 55 PGxPredict 55 Oncotype 55 percutaneous biopsy 55 induced sputum 55 HOXB# 55 cell lysate 55 kinase inhibition 55 HER2 gene 55 thyroid nodules 55 fluorogenic 55 Formalin fixed 55 protein electrophoresis 55 HLA antibody 55 hepatic lesions 55 unresectable tumors 55 Fine needle aspiration 55 breast cancer subtypes 55 proteomic analysis 55 mutated K ras 55 ERCC1 55 haematological 55 bone scintigraphy 55 NPM1 55 Situ Hybridization 55 binary logistic regression 55 β1 55 immunofluorescence 55 sestamibi 55 MR spectroscopy 55 enzyme kinetics 55 proton MR spectroscopy 55 array CGH 55 echocardiographic parameters 55 scintigraphic 55 genomic biomarkers 55 epithelial tumors 55 Cardiotoxicity 55 substrate specificity 55 cardiac magnetic resonance 55 Angiographic 55 HepG2 cells 55 bisulfite sequencing 55 preferentially bind 55 gene loci 55 Taqman 55 HER2/neu 55 PARP inhibition 55 gene expression profiles 55 NMIBC 55 clinicopathological 55 x ray angiography 55 pleural fluid 55 FDG PET 55 ELISPOT assay 55 CellSearch ™ 55 FISH fluorescence 55 assay ELISA 55 specific antigen PSA 54 kidney allograft 54 transvaginal sonography 54 transcriptome analysis 54 transesophageal echocardiography 54 QPCR 54 karyotyping 54 HBsAg 54 histone deacetylase inhibitor 54 T1 weighted images 54 miRview TM mets 54 AdnaTest 54 cystoscopic 54 inactivating mutations 54 galectin 3 54 intracellular bacteria 54 ChIP Seq 54 Crystallographic 54 stably transfected 54 miR #a [001] 54 MSH2 54 EBUS FNA 54 colorectal adenocarcinoma 54 #T# L1 54 pharmacokinetic parameters 54 ELISA assays 54 follicular fluid 54 cytologic 54 ZNF# 54 cytoreductive nephrectomy 54 Illumina GoldenGate 54 AlloMap 54 Coronary angiography 54 cTnT 54 immunofluorescence microscopy 54 metabolomic profiling 54 Septin9 54 pharmacodynamic properties 54 ELISA kit 54 transduced cells 54 glutamic acid decarboxylase 54 interobserver 54 mouse mammary 54 paraffin embedded 54 PTPN# 54 AST ALT 54 molecular assays 54 SPECT CT imaging 54 methylation biomarkers 54 PCR RFLP 54 electrocardiography ECG 54 Cervista HPV 54 PD2i ® 54 multivariate regression analysis 54 epoetin alpha 54 gene expression assays 54 transabdominal 54 fluoropyrimidine 54 pharmacodynamic biomarkers 54 LungExpress Dx 54 HER2 overexpression 54 Assay Kits 54 K RAS 54 pT2 54 PCA3 assay 54 PIB PET 54 Lymph node 54 protein microarrays 54 extracapsular extension 54 SELDI TOF 54 troponin T 54 pharmacodynamic PD 54 multigene expression test 54 PSA nadir 54 PET CT scans 54 Quantitation 54 Prognostic Value 54 quantitate 54 FDG PET scans 54 pancreatic adenocarcinoma 54 proteomic profiling 54 assay detects 54 endometrial biopsy 54 Prostate specific antigen 54 chemoresistant 54 hENT1 54 bronchoalveolar lavage fluid 54 #S rDNA 54 microarray experiments 54 vitro diagnostic multivariate 54 Upregulation 54 squamous intraepithelial lesions 54 HCV replicon 54 urodynamic 54 autoradiography 54 serum antibody 54 peritoneal carcinomatosis 54 Western Blotting 54 Pharmacokinetic parameters 54 Rating Scale BPRS 54 D dimer 54 FDG PET imaging 54 pancreatic endocrine 54 hematopoietic cancers 54 miRview ™ mets 54 Bonferroni correction 54 xCELLigence System 54 microRNA expression 54 Aspergillus nidulans 54 prognostic biomarkers 54 transient elastography 54 Septin9 biomarker 54 TIMP 1 54 HER2 positive metastatic breast 54 peptide BNP 54 PD2i R 54 DNA methylation patterns 54 EGFR mutation status 54 MabCampath 54 genotyping assay 54 prostate cancer PCa 54 cDNA microarray 54 Myocardial Perfusion Imaging 54 prognostic marker 54 C1q 54 Recurrence Score 54 transcriptome sequencing 54 molecular subtypes 54 IgG antibody 54 aminotransferase 54 cytokeratin 54 Breast Cancer Assay 54 CXCR4 expression 54 quasispecies 54 prostatic adenocarcinoma 54 GSTP1 54 SPINK1 54 ALTROPANE 54 myocardial perfusion 54 CellPort Technologies 54 differentiate squamous 54 Microarray 54 BCR ABL mutations 54 PET imaging 54 DSM IV diagnoses 54 Polymerase 54 EGFR expression 54 Pertuzumab 54 cytogenetic 54 Multivariate analysis 54 stratifying patients 54 spirometric 54 Immunotherapeutic 54 Histology 54 Solorel TM 54 serum phosphorous 54 KRAS status 54 ligand induced 54 Mutational 54 morphometry 54 lymph node metastasis 54 Optical coherence tomography 54 IGF IR 54 invasive carcinomas 54 Cardiac Marker 54 polyclonal 54 LC-MS/MS 54 Echocardiographic 54 differential gene expression 53 preoperative staging 53 ibritumomab tiuxetan 53 neovasculature 53 Reproducibility 53 histopathology 53 EGFR mutations 53 cardiac perfusion 53 MMP# 53 tolerability pharmacokinetics 53 HepDirect prodrug 53 VEGF expression 53 MLH1 53 cytological 53 serum lipid levels 53 Circulating Tumor Cells 53 nested PCR 53 neutrophil gelatinase associated lipocalin 53 KineMarker TM 53 miRNA biomarkers 53 hc2 53 mesothelin 53 convergent validity 53 intravital 53 #.#ng/ml 53 fluorescence microscopes 53 CD# CD# 53 diagnostic biomarker 53 serum antibodies 53 murine models 53 radiolabeling 53 PBMCs 53 renal tumors 53 haematologic 53 bioavailable testosterone 53 natriuretic peptide 53 NT proBNP assay 53 Tyrosine Kinase 53 CyPath ® assay 53 fulvestrant 53 Confirmatory 53 recurrent NSCLC 53 amaZon 53 erythrocyte sedimentation rate 53 Tyrosine Kinase Inhibitor 53 Tomography SPECT 53 Pharmacogenetic 53 Activity Assay 53 bovine thrombin 53 pathologic diagnosis 53 poly ADP ribose polymerase 53 Doppler echocardiography 53 ChIP 53 phenotyping 53 ultrastructural 53 lactate dehydrogenase 53 thyroid peroxidase 53 prostate adenocarcinoma 53 bioluminescence imaging 53 ADAS Cog 53 genetic polymorphisms 53 hemodynamically significant 53 LHRH receptor positive 53 CpG island 53 Scintigraphy 53 noninvasive imaging 53 ErbB2 positive 53 Fibroblast 53 radiotherapeutic 53 SSc 53 neratinib 53 NADiA ProsVue 53 metabolite profiling 53 BRAF mutation 53 fluorodeoxyglucose positron emission tomography 53 Transfection 53 clusterin 53 helical CT 53 prostate cancer CaP 53 T2DM 53 RNA extraction 53 radioimmunoassay 53 ultrasensitive detection 53 molecular determinants 53 biostatistical analysis 53 de novo sequencing 53 Genotypes 53 Cardiac Troponin 53 IFN γ 53 Histopathology 53 Protein Expression 53 mammographically 53 pretest probability 53 siRNAs targeting 53 metaplasia 53 Prostate Specific Antigen PSA 53 TaqMan assays 53 tissue transglutaminase 53 Immunoglobulin E 53 CTEPH 53 Molecular Diagnostic 53 Haptoglobin 53 lupus anticoagulant 53 renal cell carcinomas 53 HGPIN 53 PET myocardial perfusion 53 PCR assays 53 TaqMan 53 histologies 53 BioMAP 53 esophageal carcinoma 53 reverse transcription polymerase 53 nasopharyngeal swabs 53 nucleated cells 53 Tasigna prolongs 53 nucleic acid molecules 53 thyroid carcinoma 53 thymidine kinase 53 Sanger Sequencing 53 myocardial infarct size 53 diagnostic assays 53 colorectal carcinoma 53 DNA methylation profiling 53 B7 H4 53 multivariate analyzes 53 biochemical assays 53 tissue microarrays 53 estrogen receptor ER 53 K ras 53 gene expression biomarkers 53 subcellular localization 53 electrospray ionisation 53 paraffin embedded tissue 53 transcranial Doppler 53 histologic subtype 53 Cardiorespiratory fitness 53 Transcriptome 53 ELISA enzyme 53 kinase assays 53 VeraTag 53 Ultrasensitive 53 EGFR tyrosine kinase inhibitors 53 Adenomas 53 GLP toxicology studies 53 genomewide association study 53 Liver biopsies 53 fundus photography 53 miRview meso 53 Abbott RealTime 53 BMS# 53 biophysical techniques 53 obstructive coronary artery 53 SELDI 53 Circulating tumor cells 53 cisplatin resistant 53 EGFR mutation 53 antiangiogenic agent 53 PROLARIS 53 viral tropism 53 T2 weighted images 53 lymphovascular invasion 53 hemoglobin hematocrit 53 Cardiolite ® 53 EEG recordings 53 C Reactive Protein 53 Prognostic factors 53 experimentally validated 53 5 HT2A serotonin 53 Extracellular 53 Oncotype DX Recurrence Score 53 T1a 53 metastatic malignant 53 malignant lesions 53 tumor specific antigen 53 nucleic acid assays 53 hepatic fibrosis 53 Protease 53 adjuvant therapies 53 HRCT 53 amplified nucleic acid 53 oncologic outcomes 53 electron beam computed tomography 53 malignant polyps 53 Hurthle cell 53 thetreatment 53 nCounter 53 Symptom severity 53 chromosomal anomalies 53 Cytotoxicity 53 Phylogenetic analyzes 53 CTAP# Capsules 53 kinase profiling 53 N glycan 53 CYT# potent vascular disrupting 53 Human Leukocyte Antigen 53 Immunochemistry 53 Mutagenesis 52 Monoclonal 52 TaqMan ® 52 fluorodeoxyglucose 52 TMPRSS2 ERG fusion 52 HLA DR 52 seminal vesicle invasion 52 Affymetrix GeneChip 52 micronuclei 52 univariate 52 bronchoalveolar lavage BAL 52 HER3 52 antibody titer 52 NPRL2 52 potency selectivity 52 interleukin IL -# 52 Co Receptor Tropism 52 trophoblast cells 52 siRNA conjugates 52 GRNCM1 52 serological tests 52 computed tomographic 52 oncological outcomes 52 genotypic 52 validate biomarkers 52 DNMT1 52 Genomic Grade 52 chemiluminescence 52 FSH receptor 52 Positron Emission Tomography PET 52 Monogram Trofile TM 52 LV ejection fraction 52 HIV coinfected 52 PGDH 52 Galectin 3 52 powder diffraction 52 hamartomas 52 Scale PANSS 52 esophageal manometry 52 CD3 + 52 immunomodulation 52 haematopoietic 52 TIMP 52 bactericidal activity 52 HG PIN 52 arteriography 52 contrast echocardiography 52 CC genotype 52 Corus CAD 52 ptau 52 HER1 52 arthrography 52 Daptomycin 52 dosimetric 52 SNP arrays 52 inflammatory biomarkers 52 fine needle aspirate 52 PCR Polymerase Chain Reaction 52 affinity purification 52 multivariate Cox 52 breast carcinomas 52 LVNC 52 relapsed MM 52 Mesothelin 52 spiral computed tomography 52 FDG PET CT 52 PCR amplified 52 deCODE AF TM 52 untreated metastatic melanoma 52 SensoLyte ™ 52 MiCK assay 52 situ LCIS 52 Prostate Cancer Progression 52 KRAS oncogene 52 hemagglutination inhibition HAI 52 potent suppressor 52 precursor lesions 52 XL# inhibits 52 differentially expressed genes 52 interobserver reliability 52 TLE3 52 substantially excreted 52 bioassays 52 laser scanning confocal 52 FT IR spectroscopy 52 Magnetic resonance 52 Li Fraumeni 52 Repeatability 52 immunoreactive 52 Positron emission tomography PET 52 Cytotoxic T 52 BRCA2 carriers 52 nonmetastatic 52 invasive lobular carcinoma 52 VerifyNow 52 physiologically relevant 52 AttoSense 52 locoregional recurrence 52 adenoviral 52 transesophageal 52 murine model 52 molecular biomarker 52 reagent kits 52 RNA polymerases 52 genes differentially expressed 52 diagnostic prognostic 52 microvessel density 52 multivariable logistic regression 52 prognostically 52 fluorescence imaging 52 flow cytometry 52 metabonomics 52 PCR RT PCR 52 muscle biopsies 52 Neuropsychiatric Inventory NPI 52 Breast Specific 52 abnormal cytology 52 FFPE 52 tumor histology 52 spectrophotometric 52 Papillary 52 Bioanalysis 52 IL 1ß 52 distant metastasis 52 fluorescence spectroscopy 52 MSMB 52 malignant prostate 52 MAGE A3 ASCI 52 fluorescent microscopy 52 LANCE Ultra 52 Genotyping 52 sitosterol 52 HTRF R 52 LungAlert TM 52 human IgG1 monoclonal 52 Meta analyzes 52 tests miRview TM 52 radical prostatectomy RP 52 pharmacogenetic testing 52 nonsmall cell lung cancer 52 coronary stenosis 52 immunoglobulin G 52 Gastrointestinal Stromal Tumors 52 tissue oxygenation 52 antiangiogenic therapy 52 serum thyroglobulin 52 multidetector row 52 anti CD3 52 cytologic examination 52 Anti Tumor Activity 52 Elastography 52 histologically confirmed 52 taxane therapy 52 biomarker identification 52 whose tumors overexpress 52 biothreat agents 52 HER2 ErbB2 52 concurrent chemoradiation 52 multiple logistic regression 52 fine needle aspiration 52 BSGI MBI 52 serologic 52 GRAVITAS trial 52 fluorescence intensity 52 genomics transcriptomics 52 tomography PET 52 Logistic regression 52 prostate abnormalities 52 mechanistic insights 52 BRAF V#E 52 leukocyte count 52 Endoscopic ultrasound 52 Drosophila genome 52 rs# [002] 52 formalin fixed paraffin embedded 52 histological diagnosis 52 EP #R 52 ADPKD 52 perineural invasion 52 OnDose TM 52 laparoscopic radical nephrectomy 52 Chinese Hamster Ovary 52 Ultrasonographic 52 clinically localized prostate 52 skin sterol 52 antitumor effect 52 colonography 52 refractory chronic lymphocytic 52 transcranial Doppler ultrasound 52 engineered urethras 52 siRNA transfection 52 TRUS 52 optical coherence tomography OCT 52 Xpert MRSA 52 multivariate logistic regression 52 breast carcinoma 52 Intra operative 52 mutated p# 52 Clinical Validation 52 computed tomography SPECT imaging 52 mucinous 52 Mass Spectrometry ICP MS 52 Lp PLA2 52 Computed tomographic 52 Confocal microscopy 52 effector function 52 lung metastasis 52 thymosin beta 4 52 CYP#C# [002] 52 IgG antibodies 52 p# INK4a 52 Immunoassays 52 MCSP respectively 52 bacterial genomes 52 automated microscopy 52 Multivariate logistic regression 52 apolipoproteins 52 Cytogenetic 52 2 microglobulin 52 Monogram Trofile Assay 52 Factor Receptor 52 perfusion abnormalities 52 ProFlu + 52 EDEMA3 trial 52 miRview ® 52 E. faecalis 52 cardiac troponin 52 fetal aneuploidy 52 TTR gene 52 histologic subtypes 52 metastatic pancreatic 52 PiB PET 52 Biochip 52 transcriptional profiling 52 favorable pharmacokinetic profile 52 DNA Methylation 52 biopsy Gleason 52 medically inoperable 51 pCR 51 agarose gel electrophoresis 51 genomic profiling 51 MDS MPD 51 radiotracer 51 dopamine D2 51 pretransplant 51 positron emission